Utility of SHIV for testing HIV-1 vaccine candidates in macaques

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 2, 1996, Pages 99-106

  Lu, Yichen ^a   Salvato, Maria S ^b   David Pauza, C ^b   Li, John ^c   Sodroski, Joseph ^c   Manson, Kelledy ^d   Wyand, Michael ^d   Letvin, Norman ^e   Jenkins, Sharon ^a   Touzjian, Neal ^a   Chutkowski, Christine ^a   Kushner, Nicholas ^a   LeFaile, Maria ^a   Payne, Lendon G ^a   Roberts, Bryan ^a  

^a Virus Research Institute Inc Cambridge   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d TSI Mason Laboratories   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

HIV 1 vaccine; Rhesus monkeys; Simian human immunodeficiency virus chimera

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL MODEL; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION PREVENTION; INTRAVENOUS DRUG ADMINISTRATION; MONKEY DISEASE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA MULATTA; SIMIAE; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 1542639605     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199606010-00001     Document Type: Article

References (20)

1. Weiss RA, Clapham PR, Weber JN, Dalgleish AG, Lasky LA, Berman PW. Variable and conserved neutralization antigens of human immunodeficiency virus. Nature 1986;324: 572-5.
2. Li J, Lord CI, Haseltine WA, Letvin NL, Sodroski J. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J Acquir Immune Defic Syndr 1992;5:639-46.
3. Daniel M, Letvin N, King N, et al. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 1985;228: 1201-4.
4. Gilljam G. Envelope glycoprotein of HIV1, HIV2, and SIV purified with galanthus nivalis agglutinin induce strong immune responses. AIDS Res Human Retroviruses 1993;9: 431-8.
5. Kestler H, Kodama T, Ringer D, et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 1990;248:1109-12.
6. Spouge JL. Statistical analysis of sparse infection data and its implications for retroviral trials in primates. PNAS 1992; 89:7581-5.
7. Letvin NL. Vaccines against human immunodeficiency virus - progress and prospects. N Eng J Med 1993;329:1400-5.
8. Payne L, Jenkins S, Andrianov A, Langer R, Roberts B. Xenobiotic polymers as vaccine vehicles. Adv Exp Med Biol 1995;371B:1475-80.
9. Payne L, Jenkins S, Andrianov A, Roberts B. Water soluble phosphazene polymers for parenteral and mucosal vaccine delivery. In: Powell MF, Neuman MJ, eds. Vaccine design. Plenum Press, Boston (in press).
10. Berman P, Groopman J, Gregory T, et al. Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120. Proc Natl Acad Sci 1988;85:5200-4.
11. Girard M, Kieny M, Pinter A, et al. Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc Natl Acad Sci 1991;88:542-6.
12. Berman P, Gregory T, Riddle L, et al. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature 1990; 345:622-5.
13. Warren J, Dolatshahi M. Worldwide survey of AIDS vaccine challenge studies in non human primates: vaccines associated with active and passive immune protection from live virus challenge. J Med Primatol 1992;21:139-86.
14. Stott EJ. Anti-cell antibody in macaques. Nature 1991;353: 393.
15. Hartung S, Norley S, Ennen J, Cichutek K, Plesker R, Kurth R. Vaccine protection against SIVmac infection by high- but not low-dose whole inactivated virus immunogen. J Acquir Immune Defic Syndr 1992;5:461-8.
16. Osterhaus A, Vries P, Heeney J. AIDS vaccine developments. Nature 1992;355:685.
17. The European Concerted Action on Macaque Models for AIDS Research. Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: comparison of adjuvants, doses and challenge viruses. Vaccine 1995;13:295-300.
18. Daniel M, Kirshhoff F, Czajak S, Sehgal P, Desrosiers R. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992;258:1938-42.
19. Baba T, Jeong Y, Penninck D, Bronson R, Greene M, Ruprecht R. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal Macaques. Science 1995;267: 1820-5.
20. Li J, Halloran M, Lord C, et al. Persistent infection of macaques with simian-human immunodeficiency viruses. J Virol 1995;69:7061-71.